UTROGESTAN vaginaalpehmekapsel এস্তোনিয়া - এস্তোনীয় - Ravimiamet

utrogestan vaginaalpehmekapsel

besins healthcare ireland limited - progesteroon - vaginaalpehmekapsel - 200mg 21tk; 200mg 45tk; 200mg 90tk; 200mg 15tk

YALDIGO toimeainet modifitseeritult vabastav tablett এস্তোনিয়া - এস্তোনীয় - Ravimiamet

yaldigo toimeainet modifitseeritult vabastav tablett

tillotts pharma ab - mesalasiin - toimeainet modifitseeritult vabastav tablett - 1600mg 30tk; 1600mg 90tk; 1600mg 60tk

FINGOLIMOD ZENTIVA kõvakapsel এস্তোনিয়া - এস্তোনীয় - Ravimiamet

fingolimod zentiva kõvakapsel

zentiva k.s. - fingolimood - kõvakapsel - 0,5mg 28tk; 0,5mg 30tk; 0,5mg 7tk; 0,5mg 56tk

Cevenfacta ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorraagilised ained - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.

Teriflunomide Mylan ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - sclerosis multiplex, relapsing-remitting - immunosupressandid - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - sclerosis multiplex, relapsing-remitting - immunosuppressants, valikuline immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

TEREBYO õhukese polümeerikattega tablett এস্তোনিয়া - এস্তোনীয় - Ravimiamet

terebyo õhukese polümeerikattega tablett

sandoz pharmaceuticals d.d. - teriflunomiid - õhukese polümeerikattega tablett - 14mg 84tk; 14mg 28tk

TIFAY õhukese polümeerikattega tablett এস্তোনিয়া - এস্তোনীয় - Ravimiamet

tifay õhukese polümeerikattega tablett

stada arzneimittel ag - teriflunomiid - õhukese polümeerikattega tablett - 14mg 28tk; 14mg 84tk

BOXARID õhukese polümeerikattega tablett এস্তোনিয়া - এস্তোনীয় - Ravimiamet

boxarid õhukese polümeerikattega tablett

gedeon richter plc. - teriflunomiid - õhukese polümeerikattega tablett - 14mg 28tk; 14mg 14tk; 14mg 98tk; 14mg 84tk